Chemical Name: Retatrutide (LY3437943) Classification: Triple hormone receptor agonist Mechanism: GLP-1/GIP/Glucagon receptor agonist Research Applications: Metabolic pathway research Glucose regulation mechanism studies Energy expenditure analysis Lipid metabolism research Incretin hormone pathway investigation Hepatic fat reduction studies Multi-receptor agonism research Product Specifications: Form: Lyophilized powder Purity: High purity research grade Storage: Store at -20C, protect from light and moisture Reconstitution: Use bacteriostatic water (not included) Stability: 24 months when stored properly, 30 days once reconstituted Research Background: Retatrutide is an investigational triple hormone receptor agonist that simultaneously targets GLP-1, GIP, and glucagon receptors

Our infusions help your body eliminate waste more efficiently by aiding liver and kidney function, rather than forcing some dramatic "flush." It's about empowering your body's natural wisdom to restore balance and help you feel refreshed from the inside out
What does clinical evidence say about semaglutide safety in teenagers
This promising new weight loss medication, Retatrutide, is still in the clinical trial phases and is not yet approved by the FDA
Immunogenic cell death in cancer therapy
Hold the vial up to a light source, a window or a lamp